Dog Brains Could Help Crack Alzheimer’s Disease And Here’s the Research Making It Happen

Colorado State University veterinary scientists just got their biggest platform yet. Here’s why it matters for every vet and every patient you will ever see.

If you watched 60 Minutes this past weekend, you saw something that does not happen very often: veterinary medicine taking center stage on one of the most-watched news programs in the country.

Anderson Cooper sat down with two Colorado State University researchers, Dr. Stephanie McGrath, a veterinary neurologist, and Dr. Julie Moreno, a neurotoxicologist — to talk about dogs, dementia, and the possibility that our patients might hold the key to one of the most devastating and treatment-resistant diseases in human medicine. The segment, which aired to more than 8 million viewers, was called “Dog aging research may help canines, people live longer and healthier.” It was exactly the kind of moment the veterinary profession has been building toward for decades.

Here is what you need to know.

The problem they are trying to solve

Alzheimer’s disease is the leading cause of human dementia, and right now there is no broadly effective treatment. About 12 percent of people over 60 have Alzheimer’s or a related dementia. The World Health Organization projects that proportion will grow to 22 percent globally by 2050, and that Alzheimer’s and related dementias could become the second-leading cause of death in the United States within the next decade.

Progress has been painfully slow. Most studies rely on mice as a model for testing treatments, but less than 5 percent of all interventions tested in mice make it to FDA approval for humans — at least partly because mice differ significantly from humans, lack genetic diversity, live in sterile environments, and do not naturally develop dementia.

Dogs are a different story entirely.

Why dogs are the model that could actually work

Dog brains, like human brains, have a frontal lobe, temporal lobe, and occipital lobe. It is the same basic shape as the human brain. And it turns out dementia changes brain size and structure in very similar ways in both species.

Dogs share our environments and are exposed to the same pollutants, household chemicals, and toxins. They also exhibit genetic diversity and naturally develop dementia with similar biology to humans. That combination — shared environment, genetic variation, naturally occurring disease — is exactly what makes the laboratory mouse model so limited by comparison.

Canine cognitive decline may affect 35 percent of dogs older than 8. That is not a niche condition. That is a significant portion of the senior dog population that walks through veterinary doors every single day, and it looks remarkably similar to what happens in the human brain.

Under a microscope, the resemblance is striking. Dogs with dementia show beta amyloid plaques, a hallmark of Alzheimer’s in people. The brain shrinks. The spaces enlarge. The neurons die off in patterns that neuropathologists recognize from human Alzheimer’s research. This is not a loose analogy. It is the same disease process playing out in a species we spend our careers caring for.

What CSU is actually doing

McGrath and Moreno are leading a nationwide initiative called the Brain Health Study, which is part of the larger Dog Aging Project funded by the National Institutes of Health. By studying brain aging and dementia in more than 500 dogs — from the cellular to the behavioral level — the scientists hope to move toward medical treatments for neurological conditions that are typically age-related.

One of the most promising avenues is a drug called rapamycin. In mice, rapamycin has been shown to slow cognitive decline and increase life expectancy by a remarkable 60 percent. Moreno conducted a pilot study in dogs showing signs of dementia and found that dogs treated with rapamycin showed fewer microglial cells in their brains — and microglial cells produce the inflammation commonly associated with dementia progression.

Moreno describes her research as focused on understanding how cells in the brain become stressed and inflamed as they age and how that stress leads to dementias and neurodegeneration. The goal is both better diagnosis and better treatment.

The infrastructure for this research is now fully in place. The team has conducted 21 postmortem exams and built a research platform capable of longitudinal data collection, annual biospecimen collection, and postmortem sample collection across a diverse national cohort of companion dogs.

The clinical piece — what this means for veterinarians

This is the part that matters most for anyone in practice.

McGrath puts it directly: dogs can develop dementia in a way that looks very similar to Alzheimer’s disease in people. By studying it in pets, we not only learn how to better care for aging dogs, but we also gain insight that could one day help human patients and families facing the same challenges.

For the veterinarian seeing a 10-year-old Labrador whose owner says he seems confused, is pacing at night, stares at walls, forgets he just ate — this research is not abstract. It is the scientific foundation for a diagnosis that your clients desperately need you to be able to make and explain. Canine cognitive dysfunction syndrome is underdiagnosed, often because the signs are written off as normal aging. They are not normal. They are clinical. And they are now the subject of NIH-funded research that aired on national television.

The conversation this 60 Minutes segment started is one that will end up in your exam room. Pet owners who watched it, or whose family members did, are going to come in asking about cognitive decline in their dogs. They are going to ask if there are studies their dog can participate in. They are going to ask what they can do.

You are the person they are going to ask.

The bigger picture

The use of companion animals to study naturally occurring disease in both animals and people is at the heart of a movement called translational medicine. CSU has been a leader in the field for decades, notably in cancer research and care for dogs, with insights relevant to human cancer.

What is happening with canine cognitive dysfunction is the next chapter of that story. Veterinary medicine is not a support system for human medicine. It is a parallel and essential partner in understanding disease across species. The research coming out of CSU and the Dog Aging Project is proof of what this profession has always known and not always had the platform to say out loud.

Eight million people watched it on Sunday. Now they know it too.

The Dog Aging Project is actively enrolling dogs. To learn more or refer a patient, visit dogagingproject.org. The Brain Health Study at Colorado State University is led by Dr. Stephanie McGrath and Dr. Julie Moreno at the CSU College of Veterinary Medicine and Biomedical Sciences.